Mga Batayang Estadistika
| CIK | 1016708 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to RenovaCare, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| December 30, 2022 |
As filed with the Securities and Exchange Commission on December 29, 2022 As filed with the Securities and Exchange Commission on December 29, 2022 Registration No. |
|
| December 30, 2022 |
VIA EDGAR Division of Corporation Finance Securities and Exchange Commission 100 F Street, N. |
|
| December 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15-15D CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 333-222974 RenovaCare, Inc. (Exact name of registrant as speci?ed in it |
|
| December 30, 2022 |
As filed with the Securities and Exchange Commission on December 30, 2022 POS AM 1 posam123022.htm POS AM As filed with the Securities and Exchange Commission on December 30, 2022 Registration No. 333-222974 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 POST-EFFECTIVE AMENDMENT TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 3841 (State or other jur |
|
| December 30, 2022 |
As filed with the Securities and Exchange Commission on December 29, 2022 S-1/A 1 fs1a122922.htm FORM S-1/A As filed with the Securities and Exchange Commission on December 29, 2022 Registration No. 333-222974 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 POST-EFFECTIVE AMENDMENT TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada ▲ (State or other juri |
|
| November 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-30156 RENOVACARE, INC. (Exact name of registrant as specifie |
|
| November 14, 2022 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 Commission File Number: 000-30156 CUSIP Number: 75988J106 NOTIFICATION OF LATE FILING (Check One): [ ] Form 10-K [ ] Form N-SAR [ ] Form 20-F [ ] Form N-CSR [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D For Period Ended: September 30, 2022 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 10-Q [ ] Transition Report on Form 20-F [ ] Transition Report on Form N-SAR [ ] Transition Report on Form 11-K For the Transition Period Ended: Read instruction (on back page) before preparing form. |
|
| August 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-30156 RENOVACARE, INC. (Exact name of registrant as specified in |
|
| May 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-30156 RENOVACARE, INC. (Exact name of registrant as specified in |
|
| May 9, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): May 3, 2022 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I. |
|
| May 9, 2022 |
RenovaCare Announces Termination of StemCell Systems R&D Agreement EXHIBIT 99.1 RenovaCare Announces Termination of StemCell Systems R&D Agreement SCOTTSDALE, Ariz., May 03, 2022 (GLOBE NEWSWIRE) - RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for isolating and spraying cells for the regeneration of skin and other organs and tissues, today announced the termination of its July 1, 2020 Strategic Researc |
|
| March 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Exact name |
|
| March 24, 2022 |
Form of Convertible Promissory dated March 18, 2022. Exhibit 10.1 NEITHER THIS PROMISSORY NOTE NOR THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAW AND NEITHER MAY BE SOLD OR OTHERWISE TRANSFERRED UNTIL (i) A REGISTRATION STATEMENT UNDER SUCH SECURITIES ACT AND SUCH APPLICABLE STATE SECURITIES LAWS SHALL HAVE BECOME EFFECTIVE WITH REGARD THERETO, |
|
| March 24, 2022 |
Resignation Letter of Dr. Justin Frere dated March 23, 2022 Exhibit 17.2 JUSTIN FRERE RESIGNATION LETTER March 23, 2022 The Board of Directors RenovaCare, Inc. 9375 E. Shea Blvd, Suite 107-A Scottsdale, AZ 85260 Dear Harmel,: I hereby tender my resignation as the Chief Financial Officer, Treasurer and Secretary of RenovaCare, Inc. (the ?Company?), and as to any and all other positions I may hold, effective March 24, 2022. Please note that my resignation is |
|
| March 24, 2022 |
Resignation Letter of Dr. Kaiyo Nedd dated March 23, 2022 Exhibit 17.1 Resignation Notice from Kaiyo Nedd To: RenovaCare, Inc. Board of Directors From: Kaiyo Nedd Date: March 23rd, 2022 Dear Harmel, I hereby tender my resignation as a member of the Board of Directors of RenovaCare, Inc. and as its President and Chief Executive Officer, effective March 24th, 2022. Please note that this was not due to any disagreements between me and the Company on any mat |
|
| March 24, 2022 |
RenovaCare Announces Management Changes EXHIBIT 99.1 RenovaCare Announces Management Changes SCOTTSDALE, Ariz., March 24, 2022 (GLOBE NEWSWIRE) - RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for isolating and spraying cells for the regeneration of skin and other organs and tissues, today announced reductions in its management team to further streamline administrative expense |
|
| March 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): March 18, 2022 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| March 15, 2022 |
RenovaCare Provides Clinical and Corporate Update EXHIBIT 99.1 RenovaCare Provides Clinical and Corporate Update SCOTTSDALE, Ariz., March 09, 2022 (GLOBE NEWSWIRE) - RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for isolating and spraying cells for the regeneration of skin and other organs and tissues, today announced that following the review of its research and corporate activities, |
|
| March 15, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 9, 2022 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| February 3, 2022 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): January 28, 2022 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or other jurisdiction of incorporation) (Commission File Number |
|
| February 3, 2022 |
Exhibit 10.1 PURSUANT TO ITEM 601(B)(2)(II) OF REGULATION S-K, CERTAIN INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS AS [****], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. Research and Collaboration Agreement is made as of the 28 day of January, 2022 (the ?Effective Date?) by and between RenovaCare In |
|
| January 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): January 5, 2022 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| November 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-30156 RENOVACARE, INC. (Exact name of registrant as specifie |
|
| August 3, 2021 |
NITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q NITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-30156 RENOVACARE, INC. (Exact name of registrant as specified in i |
|
| July 30, 2021 |
Exhibit 10.1 Renovacare, inc. Executive Services CONSULTING AGREEMENT This Executive Services Consulting Agreement (this ?Agreement?) is dated July 26, 2021 by and between RenovaCare, Inc., a Nevada corporation (the ?Company?), and Justin Frere, an individual residing in the State of California (?Consultant?). Recitals: A. The Company wishes to engage Consultant to provide consulting services on t |
|
| July 30, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): July 26, 2021 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or other jurisdiction of incorporation) (Commission File Number) ( |
|
| July 30, 2021 |
EX-10.2 3 exh102.htm EXHIBIT 10.2 Exhibit 10.2 Non-statutory Stock Option Agreement Pursuant to The RenovaCare, Inc. 2013 Long Term Incentive Plan This Non-statutory Stock Option Agreement dated as of July 26, 2021 (the “Effective Date”) between RenovaCare, Inc., a Nevada Corporation (the “Company”), and Justin Frere, an individual residing in the State of California (the “Participant”). In consid |
|
| July 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): July 16, 2021 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Number) ( |
|
| June 1, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): May 28, 2021 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I |
|
| June 1, 2021 |
RenovaCare Responds to SEC Complaint EX-99.1 2 exh991.htm EXHIBIT 99.1 Exhibit 99.1 RenovaCare Responds to SEC Complaint Roseland, NJ – June 1st, 2021 - RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com) today announced that it intends to vigorously defend itself and its stockholders against allegations made by the U.S. Securities and Exchange Commission (“SEC”) in a civil complaint filed on May 28, 2021 regarding legacy events ( |
|
| May 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-30156 RENOVACARE, INC. (Exact name of registrant as specified in |
|
| April 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): April 7, 2021 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Number) ( |
|
| April 13, 2021 |
Termination Letter dated April 7, 2021 from Robert W. Cook Exhibit 17.1 Robert W. Cook 119 Hunterdon Blvd. Murray Hill, N.J . 0797 4 April 7, 2021 Kaiyo Nedd, MD President & CEO RenovaCare , Inc . 4 Becker Farm Road , Suite 105 Roseland, NJ 07068 DearKaiyo: Re : Termination I refer to the Employment Agreement between RenovaCare, Inc. and me dated June 15, 2020 (the " Agreement") . Based upon our recent discussions, email correspondence and the actions Har |
|
| March 31, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Exact name |
|
| March 30, 2021 |
EX-10.1 2 exh101.htm EXHIBIT 10.1 Exhibit 10.1 CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. REDACTED INFORMATION IS INDICATED BY [****]. This Separation and Release of Claims Agreement (“Agreement”) is entered into by and between RenovaCare, Inc., a Nevada corporation (the “C |
|
| March 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): March 25, 2021 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| March 30, 2021 |
RenovaCare Announces Organizational Changes and Appointment of New Officers Exhibit 99.1 RenovaCare Announces Organizational Changes and Appointment of New Officers Roseland, NJ – March 30, 2021 – RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of organs and tissues, announced today that its Chairman, Chief Executive Officer, and President, Mr. Alan Rubino, has decided to |
|
| March 30, 2021 |
Resignation Notice dated March 25, 2021 from Alan L. Rubino Exhibit 17.1 Retirement and Resignation Notice from Alan L. Rubino To: Renovacare Board of Directors From: Alan L. Rubino Date; March 25, 2021 Dear Harmel and Kaiyo, Please note that my resignation as a member of the Board of Directors of RenovaCare, Inc. and as its Chairman, President and Chief Executive Officer, effective March 25, 2021, is due to my desire to retire from full-time employment an |
|
| March 22, 2021 |
Exhibit 99.1 Written Consent DATED MARCH 16, 2021, of THE Shareholders OF RENOVACARE INC., in Lieu of SPECIAL Meeting The undersigned, being the holders of 81.7 % of the voting power of RenovaCare, Inc., a Nevada corporation (the ?Corporation?), as set forth in attachment A hereto, hereby consent as of this 16th day of March 2021 (the ?Consent?), to the adoption of the following resolutions and th |
|
| March 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): March 16, 2021 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| March 11, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): March 9, 2021 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Number) ( |
|
| March 11, 2021 |
Exhibit 99.1 1 ? 2021 RenovaCare Inc. All rights reserved. H.C. Wainwright Global Life Science Conference I March 2021 SkinGun? & CellMist? Next Generation Ultra - Gentle Cell Spray Symbol: RCAR H.C. Wainwright Global Life Science Conference Alan L. Rubino Chairman & CEO Robin A. Robinson, PhD Chief Scientific Officer Robert W. Cook Chief Financial Officer March 9 - 10, 2021 2 ? 2021 RenovaCare In |
|
| January 20, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): January 19, 2021 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| January 20, 2021 |
Exhibit 99.2 1 © 2021 RenovaCare Inc. All rights reserved. Noble Capital Markets Annual Investor Conference I January 2021 CellMist™ & SkinGun™ Symbol: RCAR RenovaCare | Noble Capital Markets 17 th Annual Investor Conference January 19, 2021 Next Generation Cell Isolation & Ultra - Gentle Cell Spray 2 © 2021 RenovaCare Inc. All rights reserved. Noble Capital Markets Annual Investor Conference I Ja |
|
| January 20, 2021 |
RenovaCare to Present at Noble Capital Markets Annual Investor Conference on January 19, 2021 EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 RenovaCare to Present at Noble Capital Markets Annual Investor Conference on January 19, 2021 ROSELAND, N.J., Jan. 19, 2021 (GLOBE NEWSWIRE) - RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, annou |
|
| December 23, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): December 23, 2020 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| December 23, 2020 |
RenovaCare Chairman Discusses 2020 Highlights and Provides 2021 Outlook EX-99.1 2 exh991.htm PRESS RELEASE EXHIBIT 99.1 RenovaCare Chairman Discusses 2020 Highlights and Provides 2021 Outlook ROSELAND, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) - RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, announced today that it has |
|
| November 19, 2020 |
EXHIBIT 99.1 RenovaCare Awarded New Patents Allowing Greater Versatility of SkinGun?; Sterility in Field Environments; Spray Solutions to Now Include Targeted Cells, Drugs or Hormones ROSELAND, N.J., Nov. 19, 2020 (GLOBE NEWSWIRE) - RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other |
|
| November 19, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): November 19, 2020 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| November 13, 2020 |
Stock Option Agreement dated as of July 30, 2020 ** EX-4.1 2 exh41.htm EXHIBIT 4.1 Exhibit 4.1 Stock Option Agreement Pursuant to RenovaCare, Inc.’s 2013 Long Term Incentive Plan THIS STOCK OPTION AGREEMENT dated as of the 30th day of July, 2020 between RenovaCare, Inc., a Nevada Corporation having an office at 4 Becker Farm Road, Suite 105, Roseland, NJ 07068 (the “Company”), and Lydia M. Evans, MD, an individual residing in the State of New York |
|
| November 13, 2020 |
Exhibit 10.4 This Right of First Refusal and Corporate Opportunities Agreement (this “Agreement”) is made as of July 29, 2020 (the “Effective Date”) by and among RenovaCare. Inc. (“RCAR” or the “Company”)), StemCell Systems GmbH (“SCS), an entity formed and existing under the laws of Germany, Jörg Gerlach, an individual (“Gerlach”) and Reinhard Bornemann, an individual (“Bornemann”). Gerlach and B |
|
| November 13, 2020 |
Director’s Offer Letter dated as of July 13, 2020 between the Company and Lydia Evans.** Exhibit 10.1 July 13, 2020 By Email Dr. Lydia Evans RE: Offer to Join the Board of Directors Dear Lydia: On behalf of RenovaCare, Inc. (the "Company"), in recognition of our belief that your skills, expertise and knowledge will prove helpful to the Company's progress, I am pleased to extend to you an offer to join the Company's Board of Directors (the "Board''), and if asked to serve or chair any |
|
| November 13, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Ex |
|
| November 13, 2020 |
Director’s Retention Letter dated as of October 8, 2020 between the Company and Kenneth Kirkland** EX-10.2 4 exh102.htm EXHIBIT 10.2 Exhibit 10.2 October 8, 2020 By Email Kenneth Kirkland RE: Retention Compensation Dear Ken: On behalf of RenovaCare, Inc. (the “Company”), in recognition of our belief that your skills, expertise and knowledge will prove helpful to the Company’s progress, I am pleased to provide the terms and conditions regarding your ongoing compensation for your services as a me |
|
| November 3, 2020 |
RenovaCare Investor Presentation Exhibit 99.1 139854384028 RenovaCare Investor Presentation October 29, 2020 C: Amit Singh; RenovaCare, Inc.; Host C: Alan Rubino; RenovaCare, Inc.; Chairman & CEO C: Dr. Robin Robinson; RenovaCare, Inc.; Chief Scientific Officer C: Robert Cook; RenovaCare, Inc.; CFO +++ presentation Amit Singh^ Good morning, ladies and gentlemen. Welcome to today's RenovaCare Investor Forum. My name is Amit Singh |
|
| November 3, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): October 29, 2020 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| November 3, 2020 |
EX-99.2 3 exh992.htm EXHIBIT 99.2 Exhibit 99.2 SkinGun Œ & CellMist Œ Next Generation Ultra - Gentle Cell Spray S y m b o l : RC A R RenovaCare Investor Forum 1 RenovaCare Investor Forum I October 2020 © 2020 RenovaCare Inc. All rights reserved. October 29, 2020 This slide deck and the accompanying oral presentation contain forward - looking statements, including, but not limited to, statements re |
|
| October 6, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): October 1, 2020 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| October 6, 2020 |
RenovaCare Elects Alan L. Rubino to Chairman of the Board of Directors EXHIBIT 99.1 RenovaCare Elects Alan L. Rubino to Chairman of the Board of Directors ROSELAND, N.J., Oct. 05, 2020 (GLOBE NEWSWIRE) - RenovaCare, Inc. (Symbol: RCAR), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced that Alan L. Rubino, Chief Executive Officer and President, has been elected to the add |
|
| October 6, 2020 |
Letter from Marcum, LLP to United States Securities and Exchange Commission dated October 1, 2020 Exhibit 16.1 |
|
| October 6, 2020 |
Supplemental Letter dated October 1, 2020 from Mr. Harmel S. Rayat. EX-17.2 3 exh172.htm EXHIBIT 17.2 EXHIBIT 17.2 Harmel S. Rayat 700 – 688 West Hastings Street Vancouver, BC, V6B 1P1 October 1st, 2020 The Board of Directors RenovaCare, Inc. 4 Becker Farm Road, Suite 105 Roseland, New Jersey 07068 Gentlemen, Please note that my resignation as a member of the Board of Directors of RenovaCare, Inc. and as Chairman thereof, effective October 1, 2020, was not due to |
|
| October 6, 2020 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): October 1 ,2020 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| October 6, 2020 |
Resignation Letter dated October 1, 2020 from Mr. Harmel S. Rayat. EX-17.1 2 exh171.htm EXHIBIT 17.1 EXHIBIT 17.1 September 30, 2020 The Board of Directors RenovaCare, Inc. 4 Becker Farm Road, Suite 105 Roseland, New Jersey 07068 Gentlemen, Please be advised that I hereby tender my resignation as a Director and Chairman of the Board of RenovaCare, Inc., effective October 1 st, 2020. Sincerely, Harmel S. Rayat |
|
| August 13, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Exact n |
|
| July 7, 2020 |
RenovaCare Launches R&D Innovation Center (Berlin) for Organ & Tissue Regeneration EX-99.1 3 exh991.htm EXHIBIT 99.1 EXHIBIT 99.1 RenovaCare Launches R&D Innovation Center (Berlin) for Organ & Tissue Regeneration ROSELAND, N.J., July 01, 2020 (GLOBE NEWSWIRE) - RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com) today announced the official launch of its new RenovaCare R&D Innovation Center in Berlin, Germany, where the Company’s patented technologies for isolating and sprayi |
|
| July 7, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): July 1, 2020 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I |
|
| July 7, 2020 |
EXHIBIT 10.1 CERTAIN INFORMATION IN THIS EXHIBIT MARKED [****] HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. Strategic Research And Development Agreement (this “Strategic R & D Agreement”) dated July 1, 2020 (the “Effective Date”) by and between RENOVACARE, INC., a Nevada corporation (the “Company”), and STEMCE |
|
| June 22, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Exact |
|
| June 19, 2020 |
EX-10.1 2 exh101.htm EXHIBIT 10.1 Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”) is entered into this 15th day of June, 2020, by and between RenovaCare, Inc., a Nevada corporation with offices at 4 Becker Farm Road, Suite 105 Roseland, NJ 07068 (the “Company”) and Robert Cook, an individual residing at119 Hunterdon Blvd Murray Hill, New Jersey 07974 (the “Employee”) |
|
| June 19, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): June 15, 2020 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Number) ( |
|
| June 19, 2020 |
EX-99.1 3 exh991.htm EXHIBIT 99.1 Exhibit 99.1 Mr. Robert W. Cook, Seasoned Biotech Executive, Joins RenovaCare as Chief Financial Officer and Board Secretary Roseland, NJ – June 16th, 2020 - RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced the a |
|
| May 29, 2020 |
Exhibit 10.2 STOCK OPTION AGREEMENT Under the RenovaCare, Inc. 2013 Long Term Incentive Plan THIS STOCK OPTION AGREEMENT dated as of the 22 day of May, 2020 between RenovaCare, Inc., a Nevada Corporation having an office at (the “Company”), and ▲ (the “Optionee”). The Optionee is an employee, officer, director of or a consultant to the Company (collectively, “Company Relationship”). In connection |
|
| May 29, 2020 |
RenovaCare Appoints Founding Director of BARDA Dr. Robin A. Robinson to Chief Scientific Officer EX-99.1 4 exh991.htm EXHIBIT 99.1 Exhibit 99.1 RenovaCare Appoints Founding Director of BARDA Dr. Robin A. Robinson to Chief Scientific Officer Roseland, NJ – May 26th, 2020 - RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced that its Vice Preside |
|
| May 29, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): May 22, 2020 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I |
|
| May 29, 2020 |
EX-10.1 2 exh101.htm EXHIBIT 10.1 Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”) is entered into this 26th day of May, 2020, by and between RenovaCare, Inc., a Nevada corporation with offices at 4 Becker Farm Road, Suite 105 Roseland, NJ 07068 (the “Company”) and Robin Robinson, Ph.D., an individual having his place of business at 20419 Peach Tree Road, Dickerson, M |
|
| May 14, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Exact name |
|
| May 13, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): May 13, 2020 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Number) (I |
|
| April 1, 2020 |
Spray-On Gene Therapy With RenovaCare SkinGun™ in New Study Underway at King’s College London EXHIBIT 99.1 Spray-On Gene Therapy With RenovaCare SkinGun™ in New Study Underway at King’s College London ROSELAND, N.J., March 30, 2020 (GLOBE NEWSWIRE) - RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, today announced that the Company’s novel SkinGun™ is now |
|
| April 1, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): March 25, 2020 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| March 30, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): March 30, 2020 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| March 16, 2020 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): March 11, 2020 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| March 16, 2020 |
RenovaCare Announces New Corporate Headquarters and Laboratory Facilities EXHIBIT 99.1 RenovaCare Announces New Corporate Headquarters and Laboratory Facilities ROSELAND, N.J., March 11, 2020 (GLOBE NEWSWIRE) - RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), today announced new corporate headquarters in Roseland, New Jersey and laboratory facilities in Berlin, Germany to advance the development of its patented technologies for spraying self-donated stem cells fo |
|
| March 10, 2020 |
Research Agreement between the Company and Kings College London of Strand dated as of March 4, 2020. EX-10.1 2 exh101.htm EXHIBIT 10.1 Exhibit 10.1 RESEARCH AGREEMENT This Agreement is made as of the 3rd day of March, 2020, by and between RenovaCare Inc, a company whose registered office is at 94 Hundred Corporate Center, 9375 E Shea Blvd., Suite 107-A Scottsdale, AZ 85260 (USA) (the ‘Company’) and King’s College London of Strand, London WC2R 2LS, United Kingdom (the ‘College’), which are also re |
|
| March 10, 2020 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): March 4, 2020 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Number) ( |
|
| December 11, 2019 |
RenovaCare Stockholder Update and 2020 Outlook from the CEO EXHIBIT 99.1 RenovaCare Stockholder Update and 2020 Outlook from the CEO SCOTTSDALE, Ariz., Dec. 05, 2019 (GLOBE NEWSWIRE) - RenovaCare, Inc. (Symbol: RCAR), developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, is pleased to provide this update from its new CEO, Mr. Alan L. Rubino, as well as his outlook for 2020. Letter |
|
| December 11, 2019 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): December 5, 2019 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Number |
|
| November 21, 2019 |
Exhibit 10.3 This Employee Invention, Non-Disclosure, Non-Competition and Non-Solicitation Agreement (hereinafter referred to as the “Agreement”) is dated as of November 15, 2019 and is by and between RenovaCare, Inc., a Nevada corporation with offices at 9375 East Shea Blvd., Suite 107-A Scottsdale, AZ 85260 (the “Company”) and Alan L. Rubino residing at 210 Old Chester Road, Essex Fells, NJ 0702 |
|
| November 21, 2019 |
Employment Agreement, dated November 15, 2019 between Alan L. Rubino and the Company Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”) is entered into this 15h day of November, 2019 (the “Effective Date”), by and between RenovaCare, Inc., a Nevada corporation with offices at 9375 East Shea Blvd., Suite 107-A Scottsdale, AZ 85260 (the “Company”) and Alan L. Rubino residing at 210 Old Chester Road, Essex Fells, NJ 07021 (the “Executive”). WHEREAS, the Co |
|
| November 21, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): November 15, 2019 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Numbe |
|
| November 21, 2019 |
RenovaCare Appoints Alan L. Rubino as President and CEO EX-99.1 5 exh991.htm EXHIBIT 99.1 Exhibit 99.1 RenovaCare Appoints Alan L. Rubino as President and CEO SCOTTSDALE, Ariz., Nov. 18, 2019 (GLOBE NEWSWIRE) - RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of tissues and organs, today announced the appointment of Alan L. Rubino as President and Chief |
|
| November 21, 2019 |
Incentive Stock Option Agreement, dated November 15, 2019 between Alan L. Rubino and the Company EX-10.2 3 exh102.htm EXHIBIT 10.2 Exhibit 10.2 STOCK OPTION AGREEMENT Under the RenovaCare, Inc. 2013 Long Term Incentive Plan THIS STOCK OPTION AGREEMENT dated as of the 15th day of November, 2019, between RenovaCare, Inc., a Nevada Corporation (the “Company”), and Alan L. Rubino (the “Optionee”). The Company and Optionee are party to that certain Employment Agreement, dated on or about the date |
|
| November 14, 2019 |
RCAR / RenovaCare, Inc. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-30156 RENOVACARE, INC. (Exact name of registrant as specifie |
|
| November 14, 2019 |
Exhibit 10.7 RENOVACARE, INC. EXECUTIVE SERVICES CONSULTING AGREEMENT This Executive Services Consulting Agreement (this "Agreement") is dated August 15, 2019, by and between RenovaCare, Inc., a Nevada corporation (the "Company''), and Robin Robinson, Ph . D., an individual having his place of business at 20419 Peach Tree Road, Dickerson, MD 20842 ("Consultant"). Recitals: A. The Company wishes to |
|
| August 26, 2019 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event Reported): August 20, 2019 RenovaCare, Inc. (Exact Name of Registrant as Specified in Charter) Nevada 000-30156 98-0384030 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| August 26, 2019 |
Dr. Robin Robinson, Founding Director of BARDA Joins RenovaCare EXHIBIT 99.1 Dr. Robin Robinson, Founding Director of BARDA Joins RenovaCare SCOTTSDALE, Ariz., Aug. 20, 2019 (GLOBE NEWSWIRE) - RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of tissues and organs, is pleased to announce the appointment of its Vice President of Scientific Affairs, Dr. Robin A. Ro |
|
| August 21, 2019 |
Exhibit 10.1 Renovacare, inc. Executive Services CONSULTING AGREEMENT This Executive Services Consulting Agreement (this “Agreement”) is dated August 15, 2019, by and between RenovaCare, Inc., a Nevada corporation (the “Company”), and Robin Robinson, Ph.D., an individual having his place of business at 20419 Peach Tree Road, Dickerson, MD 20842 (“Consultant”). Recitals: A. The Company wishes to en |
|
| August 21, 2019 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 15, 2019 Date of Report (Date of earliest event reported) RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-30156 (Commission File Number) 98-0384 |
|
| August 20, 2019 |
Exhibit 99.1 RenovaCare Awarded New Patent Allowing for the Spray of Stem Cells for Regeneration of Organs and Tissues Scottsdale, AZ – August 14th, 2019 - RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com) today announced the issuance of a new patent (U.S. Patent Number 10,376,658) allowing the Company’s novel medical device to now spray all varieties of tissues and cells, thus opening the do |
|
| August 20, 2019 |
Financial Statements and Exhibits, Other Events 8-K 1 f8k081919.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 14, 2019 Date of Report (Date of earliest event reported) RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-30156 (Co |
|
| July 31, 2019 |
RCAR / RenovaCare, Inc. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-30156 RENOVACARE, INC. (Exact name of registrant as specified in |
|
| July 31, 2019 |
Charitable Gift Agreement with the University of Pittsburgh dated June 3, 2019* EXHIBIT 10.6 C HARITABLE G IFT A GREEMENT This Gift Agreement (the “Agreement”) is made as of June 3 , 2019 (the “Effective Date”) by and between RenovaCare, Inc . (the “Donor”) and the University of Pittsburgh – of the Commonwealth System of Higher Education, a Pennsylvania non - profit corporation (the “University”) . In consideration of the mutual promises and covenants herein, the sufficiency |
|
| July 3, 2019 |
Exhibit 10.1 Renovacare, inc. Executive Services CONSULTING AGREEMENT This Executive Services Consulting Agreement (this “Agreement”) is dated July 1, 2019, by and between RenovaCare, Inc., a Nevada corporation (the “Company”), and Rodney L. Sparks, an individual having his place of business at 132 Dally Court, Dripping Springs, Texas (“Consultant”). Recitals: A. The Company wishes to engage Consu |
|
| July 3, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 27, 2019 Date of Report (Date of earliest event reported) RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-30156 (Commission File Number) 98-038403 |
|
| July 3, 2019 |
RenovaCare Appoints VP to Expand and Accelerate Intellectual Property and Licensing EX-99.1 3 exh991.htm EXHIBIT 99.1 EXHIBIT 99.1 RenovaCare Appoints VP to Expand and Accelerate Intellectual Property and Licensing SCOTTSDALE, Ariz., June 27, 2019 (GLOBE NEWSWIRE) - RenovaCare, Inc., (Symbol: RCAR; www.renovacareinc.com), developer of the SkinGun™ and other patented technologies for spraying a patient’s own stem cells onto burns and wounds for accelerated self-healing, is pleased |
|
| June 10, 2019 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 f8k060719.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 4, 2019 Date of Report (Date of earliest event reported) RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-30156 (Commi |
|
| June 10, 2019 |
Exhibit 10.1 Renovacare, inc. Executive Services CONSULTING AGREEMENT This Executive Services Consulting Agreement (this “Agreement”) is dated June 4, 2019, by and between RenovaCare, Inc., a Nevada corporation (the “Company”), and Roger Esteban-Vives, an individual having his place of business in London, England (“Consultant”). Recitals: A. The Company wishes to engage Consultant to provide consu |
|
| June 7, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 3, 2019 Date of Report (Date of earliest event reported) RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-30156 (Commission File Number) 98-0384030 |
|
| May 15, 2019 |
RCAR / RenovaCare, Inc. 10-Q Quarterly Report FORM 10-Q 10-Q 1 f10q051319.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 000-30156 RENOVACARE, INC. (Exact na |
|
| April 12, 2019 |
RCAR / RenovaCare, Inc. FORM 10-K (Annual Report) 10-K 1 rcar10k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 |
|
| April 4, 2019 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 30, 2019 Date of Report (Date of earliest event reported) RenovaCare, Inc. (Exatct name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-30156 (Commission File Number) 98-0384030 (I.R.S. Em |
|
| April 4, 2019 |
EXHIBIT 10.1 TERMINATION AGREEMENT Termination Agreement dated March 30, 2019 (this “Termination Agreement”), between Thomas Bold, an individual (the “Consultant”), and RenovaCare, Inc., a Nevada corporation having its principal office at 9375 East Shea Blvd., Suite 107-A, Scottsdale, AZ 85260 (the “Company”, and together with the Consultant, the “Parties”, and each, a “Party”). WHEREAS, the Parti |
|
| April 1, 2019 |
RCAR / RenovaCare, Inc. NT 10-K NT 10-K 1 rcarnt10k.htm NT 10-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 Commission File Number: 000-30156 CUSIP Number: 75988J106 NOTIFICATION OF LATE FILING (Check One): x Form 10-K ¨ Form N-SAR ¨ Form 20-F ¨ Form N-CSR ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D For Period Ended: December 31, 2018 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 10-Q ¨ Transition |
|
| November 30, 2018 |
EXHIBIT 10.1 RENOVACARE, INC. FORM OF SUBSCRIPTION AGREEMENT This Subscription Agreement (this “Agreement”) is entered into by and between Renovacare, Inc., a corporation organized under the laws of the State of Nevada (the “Company”) and the subscriber whose name is set forth on the signature pages affixed hereto (the “Subscriber”). R E C I T A L S: Whereas, the Company is offering (the “Offering |
|
| November 30, 2018 |
EX-4.1 2 rcarex41.htm FORM OF WARRANT EXHIBIT 4.1 Form of Series I Common Stock Warrant NEITHER THIS SECURITY NOR ANY SECURITIES WHICH MAY BE ISSUED UPON EXERCISE OF THIS SECURITY HAVE BEEN REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY U.S. STATE OR OTHER JURISDICTION OR ANY EXCHANGE OR SELF-REGULATORY ORGANIZATION, IN RELIANCE UPON EXEMPT |
|
| November 30, 2018 |
EXHIBIT 10.2 AMENDMENT TO THE FEBRUARY 2017 LOAN AGREEMENT THIS AMENDMENT No. 2 dated as of November 26, 2018 (this “Agreement”) to the February 23, 2017 Loan Agreement (the “February 2017 Loan Agreement”) is entered into, by and between RenovaCare, Inc., a Nevada corporation (the “Borrower”), and Kalen Capital Corporation (“KCC”), a corporation organized under the laws of the Province of Alberta, |
|
| November 30, 2018 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 26, 2018 Date of Report (Date of earliest event reported) RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-30156 (Commission File Number) 59-3509694 (I.R.S. |
|
| November 30, 2018 |
EX-10.3 5 rcarex103.htm AMENDMENT TO SEPTEMBER 9, 2016 AGREEMENT EXHIBIT 10.3 AMENDMENT TO THE SEPTEMBER 2016 LOAN AGREEMENT THIS AMENDMENT No. 2 dated as of November 26, 2018 (this “Agreement”) to the September 9, 2016 Loan Agreement (the “September 2016 Loan Agreement”) is entered into, by and between RenovaCare, Inc., a Nevada corporation (the “Borrower”), and Kalen Capital Corporation (“KCC”), |
|
| November 19, 2018 |
RCAR / RenovaCare, Inc. FORM 10-Q (Quarterly Report) 10-Q 1 rcar10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 0 |
|
| November 14, 2018 |
RCAR / RenovaCare, Inc. NT 10-Q SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 Commission File Number: 000-30156 CUSIP Number: 75988J106 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: September 30, 2018 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Form 20-F ¨ Transition Report on Form N-SAR ¨ Transition Report on Form 11-K For the Transition Period Ended: Read instruction (on back page) before preparing form. |
|
| October 26, 2018 |
Letter from Peterson Sullivan, LLP to U.S. Securities and Exchange Commission dated October 26, 2018 EXHIBIT 16.1 October 26, 2018 United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-7561 Commissioners: We have read Item 4.01 of Form 8-K dated on October 22, 2018 of Renovacare, Inc. and are in agreement with the statements contained therein concerning our firm. /s/ PETERSON SULLIVAN LLP |
|
| October 26, 2018 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 22, 2018 Date of Report (Date of earliest event reported) RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-30156 (Commission File Number) 98-0384030 (I.R.S. E |
|
| August 9, 2018 |
RCAR / RenovaCare, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Exact n |
|
| June 25, 2018 |
EX-10.1 2 rcarex101.htm CONSULTING AGREEMENT EXHIBIT 10.1 EXECUTIVE CONSULTING AGREEMENT THIS AT-WILL EXECUTIVE CONSULTING AGREEMENT (this “Agreement”), dated as of June 22, 2018, and effective as of June 11, 2018 (the “Effective Date”), is entered into by and between RenovaCare, Inc. (the “Company”), and Vector Asset Management, Inc., a British Columbia, Canada corporation (“Consultant”). The Com |
|
| June 25, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 22, 2018 Date of Report (Date of earliest event reported) RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-30156 (Commission File Number) 98-038403 |
|
| June 15, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 11, 2018 Date of Report (Date of earliest event reported) RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-30156 (Commission File Number) 98-038403 |
|
| May 14, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Exact |
|
| April 25, 2018 |
RENOVACARE, INC. 4,404,136 SHARES OF COMMON STOCK 424B4 1 rcar424b4.htm 424B4 PROSPECTUS Filed pursuant to Rule 424(b)(4) Registration No. 333-222974 RENOVACARE, INC. 4,404,136 SHARES OF COMMON STOCK This prospectus relates to the resale by certain of our stockholders and holders of warrants to purchase our stock named in the section of this prospectus titled “Selling Stockholders” (collectively, the “Selling Stockholders”) of up to 4,404,136 sha |
|
| April 18, 2018 |
RCAR / RenovaCare, Inc. POS AM As filed with the U.S. Securities and Exchange Commission on April 18, 2018 Registration No. 333-222974 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 3841 98-0384030 (State or other jurisdiction o |
|
| April 16, 2018 |
RCAR / RenovaCare, Inc. CORRESP 230 Park Avenue 11th Floor New York, NY 10169-0079 (212) 818-9200 (212) 818-9606 (Fax) 51 John F. |
|
| April 13, 2018 |
RCAR / RenovaCare, Inc. CORRESP RenovaCare, Inc. Pittsburgh Life Sciences Greenhouse 2425 Sidney Street Pittsburgh, PA 15203 (888) 398-0202 April 13, 2018 Via EDGAR United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, DC 20549 Re: RenovaCare, Inc. Registration Statement on Form S-1, originally filed on February 12, 2018 and as amendment on April 6, 2018 File No. 333-222974 T |
|
| April 5, 2018 |
Subsidiaries of the Registrant EXHIBIT 21 Subsidiaries of the Registrant RenovaCare, Inc. ↓ 100% ↓ RenovaCare Sciences Corp. |
|
| April 5, 2018 |
RCAR / RenovaCare, Inc. FORM S-1/A S-1/A 1 rcars1a.htm FORM S-1/A As filed with the U.S. Securities and Exchange Commission on April 5, 2018 Registration No. 333-222974 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 PRE-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 3841 98-0384030 (State or |
|
| March 26, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 21, 2018 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 000-30156 98-0384030 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| March 26, 2018 |
March 21, 2018 08:30 AM Eastern Daylight Time EX-99.1 2 rcarex991.htm PRESS RELEASE EXHIBIT 99.1 March 21, 2018 08:30 AM Eastern Daylight Time PITTSBURGH & BERLIN-(BUSINESS WIRE)-RenovaCare, Inc., (RCAR), developer of the SkinGun™ and CellMist™ System for spraying a patient’s own skin stem cells onto burns and wounds for rapid self-healing, today announced the appointment of Mr. Harmel S. Rayat, longtime majority stockholder, as Chairman of i |
|
| March 13, 2018 |
January 29, 2018 First Amendment to Loan Agreement dated September 9, 2016 EX-10.27 7 rcarex1027.htm FIRST AMENDMENT TO LOAN AGREEMENT EXHIBIT 10.27 This FIRST AMENDMENT dated January 29, 2018 (this “Amendment”) to the Loan Agreement dated September 9, 2016 (the “Loan Agreement”) by and between RENOVACARE, Inc., a Nevada corporation (the “Borrower”) and Kalen Capital Corporation (“Payee”). All Capitalized terms used herein and not otherwise defined shall have the meaning |
|
| March 13, 2018 |
EX-10.25 5 rcarex1025.htm AMENDMENT TO CONSULTING AGREEMENT EXHIBIT 10.25 |
|
| March 13, 2018 |
Corporate Research Agreement dated August 1, 2017 EX-10.24 4 rcarex1024.htm CORPORATE RESEARCH AGREEMENT EXHIBIT 10.24 Pitt Ref: #0057392 CORPORATE RESEARCH AGREEMENT THIS AGREEMENT is entered into as of the 1. day of August, 2017 (the “Effective Date”), by and between RENOVACARE INC., a corporation organized under the laws of the State of New York, and having an office at 430 Park Avenue, Suite 702 New York, NY 10022 (the “Company”), and the UNI |
|
| March 13, 2018 |
RCAR / RenovaCare, Inc. FORM 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Exact name |
|
| March 13, 2018 |
January 29, 2018 First Amendment to Loan Agreement dated February 23, 2017 EX-10.26 6 rcarex1026.htm FIRST AMENDMENT TO LOAN AGREEMENT EXHIBIT 10.26 This FIRST AMENDMENT dated January 29, 2018 (this “Amendment”) to the Loan Agreement dated February 23, 2017 (the “Loan agreement”) by and between RENOVACARE, Inc., a Nevada corporation (the “Borrower”) and Kalen Capital Corporation (“Creditor”). All Capitalized terms used herein and not otherwise defined shall have the mean |
|
| March 13, 2018 |
January 29, 2018 Amendment to Convertible Promissory Note dated September 9, 2016 EX-10.23 3 rcarex1023.htm AMENDMENT TO CONVERTIBLE PROMISSORY NOTE EXHIBIT 10.23 FIRST AMENDMENT TO CONVERTIBLE PROMISSORY NOTE This FIRST AMENDMENT (this “Amendment”) to the Convertible Promissory Note dated September 9, 2016 (the “Promissory Note”). WHEREAS, the Borrower and the Payee are parties to a Loan Agreement dated September 9, 2016 (the “Loan Agreement”); WHEREAS, pursuant to the Loan Ag |
|
| March 13, 2018 |
January 29, 2018 Amendment to Convertible Promissory Note dated February 23, 2017 EX-10.22 2 rcarex1022.htm AMENDMENT TO CONVERTIBLE PROMISSORY NOTE EXHIBIT 10.22 FIRST AMENDMENT TO CONVERTIBLE PROMISSORY NOTE This FIRST AMENDMENT DATED JANUARY 29, 2018 (this “Amendment”) to the Convertible Promissory Note dated February 23, 2017 (the “Promissory Note”). WHEREAS, the Borrower and the Payee are parties to a Loan Agreement dated February 23, 2017 (the “Loan Agreement”); WHEREAS, |
|
| February 27, 2018 |
Financial Statements and Exhibits, Other Events rcar8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 21, 2018 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 000-30156 98-0384030 (State or other jurisdiction of incorporation) (Commis |
|
| February 27, 2018 |
Burned State Trooper Leaves Hospital 4 Days After RenovaCare Stem Cell Spray rcarex991.htm EXHIBIT 99.1 RenovaCare Secures Patent Victory and Continues to Bolster IP Portfolio PITTSBURGH & BERLIN ? February 21, 2018 ? RenovaCare, Inc., (RCAR), developer of the SkinGun? and CellMist? System for spraying a patient?s own skin stem cells onto burns and wounds for rapid self-healing, announced it has decisively won against patent challenger, Avita Medical, in a proceeding at th |
|
| February 20, 2018 |
RCAR / RenovaCare, Inc. POS AM rcarposam.htm As filed with the U.S. Securities and Exchange Commission on February 20, 2018 Registration No. 333-198600 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 POST EFFECTIVE AMENDMENT NO. 3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 3841 98-0384030 (State or other jurisdict |
|
| February 12, 2018 |
As filed with the U.S. Securities and Exchange Commission on February 9, 2018 S-1 1 rcars1.htm FORM S-1 As filed with the U.S. Securities and Exchange Commission on February 9, 2018 Registration No. 333-[●] U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 3841 98-0384030 (State or other jurisdiction of incorporation or |
|
| January 12, 2018 |
Financial Statements and Exhibits, Other Events rcar8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2018 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 000-30156 98-0384030 (State or other jurisdiction of incorporation) (Commissi |
|
| January 12, 2018 |
edgarproof.pdf EXHIBIT 99.1 1 2 3 4 5 6 7 8 9 |
|
| January 12, 2018 |
RENOVACARE COMMENTS ON RECENT MARKET ACTIVITY rcarex992.htm EXHIBIT 99.2 RENOVACARE COMMENTS ON RECENT MARKET ACTIVITY New York & Pittsburgh & Berlin ? January 8th, 2018 ? RenovaCare, Inc. (?RenovaCare? or the ?Company?) (OTCQB: RCAR), developer of the SkinGun? and CellMist? System for isolating and spraying a patient?s own stem cells onto burns and wounds for rapid self-healing, today announced that on January 3rd, 2018, OTC Markets Group In |
|
| November 14, 2017 |
RCAR / RenovaCare, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Ex |
|
| October 31, 2017 |
rcarposam.htm As filed with the U.S. Securities and Exchange Commission on October 31, 2017 Registration No. 333- 217499 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 3841 98-0384030 (State or oth |
|
| October 23, 2017 |
rcars3a.htm As filed with the U.S. Securities and Exchange Commission on October 23, 2017 Registration No. 333- 217499 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 3841 98-0384030 (State or other |
|
| October 20, 2017 |
Renovacare, Inc. Closes Registered Direct Offering and Concurrent Private Placement rcar_ex991.htm EXHIBIT 99.1 Renovacare, Inc. Closes Registered Direct Offering and Concurrent Private Placement New York, Pittsburgh and Berlin– October 20, 2017 – RenovaCare, Inc., (OTCQB: RCAR), developer of the SkinGun™ and CellMist™ System for isolating and spraying a patient’s own stem cells onto burns and wounds for rapid self-healing,, today announced the closing of its previously announced |
|
| October 20, 2017 |
Financial Statements and Exhibits, Other Events rcar8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 19, 2017 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 000-30156 98-0384030 (State or other jurisdiction of incorporation) (Commiss |
|
| October 18, 2017 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 16, 2017 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 000-30156 98-0384030 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| October 18, 2017 |
rcar424b5.htm Filed Pursuant to Rule 424(b)(5) Registration No. 333-217499 RENOVACARE, INC. PROSPECTUS SUPPLEMENT To Prospectus dated May 17, 2017 920,000 Shares of Common Stock We are offering 920,000 shares (which we refer to herein as the Shares) of our common stock, par value $0.00001 per share pursuant to this prospectus supplement and the accompanying base prospectus. The sales will be made |
|
| October 17, 2017 |
EX-10.1 3 rcarex101.htm FORM OF SECURITIES PURCHASE AGREEMENT EXHIBIT 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Purchase Agreement”) is entered into by and between Renovacare, Inc., a Nevada corporation (the “Company”) and the subscriber whose name is set forth on the signature pages affixed hereto (the “Subscriber”) is dated as of October 16, 2017. WHEREAS, the |
|
| October 17, 2017 |
RenovaCare, Inc. Closes Registered Direct Offering and Concurrent Private Placement rcarex991.htm EXHIBIT 99.1 RenovaCare, Inc. Closes Registered Direct Offering and Concurrent Private Placement New York, Pittsburgh and Berlin– October 17, 2017 – RenovaCare, Inc., (OTCQB: RCAR), developer of the SkinGun™ and CellMist™ System for isolating and spraying a patient’s own stem cells onto burns and wounds for rapid self-healing, today announced that it has entered into definitive agree |
|
| October 17, 2017 |
8-K 1 rcar8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 16, 2017 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 000-30156 98-0384030 (State or other jurisdiction of incorpor |
|
| October 17, 2017 |
rcarex41.htm EXHIBIT 4.1 NEITHER THIS SECURITY NOR ANY SECURITIES WHICH MAY BE ISSUED UPON EXERCISE OF THIS SECURITY HAVE BEEN REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY U.S. STATE OR OTHER JURISDICTION OR ANY EXCHANGE OR SELF-REGULATORY ORGANIZATION, IN RELIANCE UPON EXEMPTIONS FROM REGISTRATION UNDER THE UNITED STATES SECURITIES ACT O |
|
| August 14, 2017 |
RCAR / RenovaCare, Inc. FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Exact n |
|
| July 24, 2017 |
rcar8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 19, 2017 Date of Report (Date of earliest event reported) RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-30156 (Commission File Number |
|
| July 24, 2017 |
rcarex101.htm EXHIBIT 10.1 Subscription Agreement This Subscription Agreement (this ?Agreement?) is entered into by and between RenovaCare, Inc., a corporation organized under the laws of the State of Nevada (the ?Company?) and the subscriber whose name is set forth on the signature pages affixed hereto (the ?Subscriber?) as of July 19, 2017 (the ?Effective Date?). R E C I T A L S: A. This Agreeme |
|
| July 24, 2017 |
rcarex41.htm EXHIBIT 4.1 Form of Series G Warrant NEITHER THIS SECURITY NOR ANY SECURITIES WHICH MAY BE ISSUED UPON EXERCISE OF THIS SECURITY HAVE BEEN REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY U.S. STATE OR OTHER JURISDICTION OR ANY EXCHANGE OR SELF-REGULATORY ORGANIZATION, IN RELIANCE UPON EXEMPTIONS FROM REGISTRATION UNDER THE UNITE |
|
| June 29, 2017 |
rcarcorresp.htm RenovaCare, Inc. 430 Park Avenue Suite 702 New York, NY 10022 Via EDGAR United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, DC 20549 June 29, 2017 Re: RenovaCare, Inc. Registration Statement On Form S-1 File No. 333-215661 To whom it may concern, On behalf of RenovaCare, Inc. (the ?Registrant?) and in accordance with Rule 461 |
|
| June 6, 2017 |
As filed with the U.S. Securities and Exchange Commission on June 6 , 2017 As filed with the U.S. Securities and Exchange Commission on June 6 , 2017 Registration No. 333-215661 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 PRE-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 3841 98-0384030 (State or other jurisdiction of incorpora |
|
| May 16, 2017 |
rcar8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 11, 2017 Date of Report (Date of earliest event reported) RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 000-30156 98-0384030 (State or other jurisdiction of incorporation) (Commission F |
|
| May 16, 2017 |
rcarcorresp.htm RenovaCare, Inc. 430 Park Avenue Suite 702 New York, NY 10022 May 16, 2017 Via EDGAR United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, DC 20549 Re: RenovaCare, Inc. Registration Statement on Form S-3 File No. 333-217499 To whom it may concern, On behalf of RenovaCare, Inc. (the ?Registrant?) and in accordance with Rule 461 o |
|
| May 12, 2017 |
rcars3a.htm As filed with the U.S. Securities and Exchange Commission on May 1 2 , 2017 Registration No. 333- 217499 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Pre-Effective A mendment No. 1 to FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 3841 98-0384030 (State or other j |
|
| May 3, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Exact |
|
| April 27, 2017 |
rcars3.htm As filed with the U.S. Securities and Exchange Commission on April 27, 2017 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 3841 98-0384030 (State or other jurisdiction of incorporation or organizati |
|
| April 27, 2017 |
EX-99.1 2 rcarex991.htm PRESS RELEASE EXHIBIT 99.1 Outcomes of Burn Patients Treated with Cell Spray Technology Behind RenovaCare SkinGun™ Published in Prestigious Medical Journal New York & Pittsburgh – April 27, 2017 - RenovaCare, Inc. (OTCQB: RCAR), highlighted an analysis of treatment results on a variety of wide-area and severe burn injuries published in Burns, the peer-reviewed Journal of th |
|
| April 27, 2017 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events rcar8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 4, 2017 Date of Report (Date of earliest event reported) RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-30156 (Commission File Number |
|
| April 7, 2017 |
As filed with the U.S. Securities and Exchange Commission on April 7, 2017 As filed with the U.S. Securities and Exchange Commission on April 7, 2017 Registration No. 333-215661 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 3841 98-0384030 (State or other jurisdiction of incorporation or organi |
|
| March 28, 2017 |
EX-10.4 2 rcarex104.htm AMENDMENT TO CONSULTING AGREEMENT EXHIBIT 10.4 |
|
| March 28, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Exact name |
|
| March 14, 2017 |
EX-4.1 2 rcarex41.htm CONVERTIBLE PROMISSORY EXHIBIT 4.1 PROMISSORY NOTE $25,000 March 9, 2017 FOR VALUE RECEIVED, the undersigned RenovaCare, Inc., a Nevada corporation having its principal place of business at 430 Park Avenue, Suite 702, New York, NY 10022 (“Borrower”), hereby promises to pay to the order of [****] (“Payee”), in lawful money of the United States of America, the principal sum of |
|
| March 14, 2017 |
EX-10.1 3 rcarex101.htm LOAN AGREEMENT EXHIBIT 10.1 Loan Agreement THIS LOAN AGREEMENT is dated as of March 9, 2017, by and between RenovaCare, Inc., a corporation organized under the laws of the State of Nevada (“Borrower”), and [****] (“Creditor”). W I T N E S S E T H: WHEREAS, Creditor has agreed to make a loan to Borrower, and Borrower has agreed to accept a loan from Creditor, of up to [****] |
|
| March 14, 2017 |
rcar8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 9, 2017 Date of Report (Date of earliest event reported) RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 000-30156 98-0384030 (State or other jurisdiction of incorporation) (Commission |
|
| March 14, 2017 |
rcarex102.htm EXHIBIT 10.2 Amendment to Loan Agreement THIS AMENDMENT TO LOAN AGREEMENT is dated as of March 9, 2017 (this ?Amendment?), by and between RenovaCare, Inc., a corporation organized under the laws of the State of Nevada (?Borrower?), and Joseph Sierchio, a resident of the State of New York (?Creditor?). W I T N E S S E T H: WHEREAS, Creditor and Borrower have entered into a loan agreem |
|
| March 14, 2017 |
rcarex103.htm EXHIBIT 10.3 Amendment to Loan Agreement THIS AMENDMENT TO LOAN AGREEMENT is dated as of March 9, 2017 (this “Amendment”), by and between RenovaCare, Inc., a corporation organized under the laws of the State of Nevada (“Borrower”), and Kalen Capital Corporation, a corporation organized under the laws of Alberta, Canada (“Creditor”). W I T N E S S E T H: WHEREAS, Creditor and Borrower |
|
| March 1, 2017 |
rcarex101.htm EXHIBIT 10.1 Loan Agreement THISLOAN AGREEMENT is dated as of February 23, 2017, by and between RenovaCare, Inc., a corporation organized under the laws of the State of Nevada (“Borrower”), and [****] (“Creditor”). W I T N E S S E T H: WHEREAS, Creditor has agreed to make a loan to Borrower, and Borrower has agreed to accept a loan from Creditor, of up to [****] DOLLARS (US$[****]) ( |
|
| March 1, 2017 |
EX-4.2 3 rcarex42.htm FORM OF SERIES F STOCK PURCHASE WARRANT EXHIBIT 4.2 NEITHER THIS SECURITY NOR ANY SECURITIES WHICH MAY BE ISSUED UPON EXERCISE OF THIS SECURITY HAVE BEEN REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY U.S. STATE OR OTHER JURISDICTION OR ANY EXCHANGE OR SELF-REGULATORY ORGANIZATION, IN RELIANCE UPON EXEMPTIONS FROM REGI |
|
| March 1, 2017 |
rcarex41.htm EXHIBIT 4.1 PROMISSORY NOTE $[****] February 23, 2017 FOR VALUE RECEIVED, the undersigned RenovaCare, Inc., a Nevada corporation having its principal place of business at 430 Park Avenue, Suite 702, New York, NY 10022 (“Borrower”), hereby promises to pay to the order of [****] (“Payee”), in lawful money of the United States of America, the principal sum of [****] DOLLARS ($[****]), to |
|
| March 1, 2017 |
rcar8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 23, 2017 Date of Report (Date of earliest event reported) RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-30156 (Commission File Nu |
|
| January 23, 2017 |
EX-24.1 4 rcarex241.htm POWER OF ATTORNEY EXHIBIT 24.1 KNOW ALL MEN BY THESE PRESENTS, that we, the undersigned officers and directors of RenovaCare, Inc., a Nevada corporation, do hereby constitute and appoint Thomas Bold, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for him or and in his or her name, place, and stead, in any and a |
|
| January 23, 2017 |
As filed with the U.S. Securities and Exchange Commission on January 23, 2017 S-1 1 rcars1.htm FORM S-1 As filed with the U.S. Securities and Exchange Commission on January 23, 2017 Registration No. 333- U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 3841 98-0384030 (State or other jurisdiction of incorporation or or |
|
| November 14, 2016 |
10,740,000 SHARES RENOVACARE, INC. COMMON STOCK rcar424b7.htm Prospectus Supplement to Filed pursuant to Rule 424(b)(7) Prospectus dated April 14, 2016 Registration No. 333-198600 10,740,000 SHARES RENOVACARE, INC. COMMON STOCK This prospectus supplement amends and supplements our prospectus dated April 14, 2016. The prospectus relates to 10,740,000 shares of our common stock that may be offered for resale by the Selling Stockholders named ther |
|
| November 10, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Ex |
|
| September 16, 2016 |
EX-4.1 2 rcarex41.htm CONVERTIBLE PROMISSORY NOTE EXHIBIT 4.1 PROMISSORY NOTE $700,000 September 9, 2016 FOR VALUE RECEIVED, the undersigned RenovaCare, Inc., a Nevada corporation having its principal place of business at 430 Park Avenue, Suite 702, New York, NY 10065 (“Borrower”), hereby promises to pay to the order of Kalen Capital Corporation, an Alberta, Canada corporation having its principal |
|
| September 16, 2016 |
rcarex42.htm EXHIBIT 4.2 NEITHER THIS SECURITY NOR ANY SECURITIES WHICH MAY BE ISSUED UPON EXERCISE OF THIS SECURITY HAVE BEEN REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY U.S. STATE OR OTHER JURISDICTION OR ANY EXCHANGE OR SELF-REGULATORY ORGANIZATION, IN RELIANCE UPON EXEMPTIONS FROM REGISTRATION UNDER THE UNITED STATES SECURITIES ACT O |
|
| September 16, 2016 |
8-K 1 rcar8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 9, 2016 Date of Report (Date of earliest event reported) RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-30156 (Com |
|
| September 16, 2016 |
EX-10.1 4 rcarex101.htm LOAN AGREEMENT EXHIBIT 10.1 LOAN AGREEMENT THIS LOAN AGREEMENT is dated as of September 9, 2016, by and between RenovaCare, Inc., a corporation organized under the laws of the State of Nevada (“Borrower”), and Kalen Capital Corporation, a corporation organized under the laws of Alberta, Canada (“Creditor”). W I T N E S S E T H: WHEREAS, Creditor has agreed to make a loan to |
|
| August 15, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Exact n |
|
| August 3, 2016 |
rcar1512ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0167 Expires: March 31, 2018 Estimated average burden hours per response . . . . . 1.50 FORM 15/A CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF T |
|
| June 10, 2016 |
rcar1512g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0167 Expires: March 31, 2018 Estimated average burden hours per response . . . . . 1.50 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE |
|
| May 11, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Exact |
|
| April 14, 2016 |
As filed with the U.S. Securities and Exchange Commission on April 14, 2016 As filed with the U.S. Securities and Exchange Commission on April 14, 2016 Registration No. 333-198600 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 POST EFFECTIVE AMENDMENT NO. 2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 7389 98-0384030 (State or other jurisdiction of incorporat |
|
| March 28, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Exact name |
|
| March 21, 2016 |
rcar8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 16, 2016 Date of Report (Date of earliest event reported) RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-30156 (Commission File Numbe |
|
| January 11, 2016 |
RCAR / RenovaCare, Inc. / RAYAT HARMEL S - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* RenovaCare, Inc. (Name of Issuer) Common Stock, par value $0.00001 (Title of Class of Securities) 75988J106 (CUSIP Number) Harmel S. Rayat 700-688 West Hastings St. Vancouver, BC V6B 1P1 (604) 336-8600 Name, Address and Telephone Number of Person Authoriz |
|
| January 11, 2016 |
RCAR / RenovaCare, Inc. / Sidhu Jeet - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* RenovaCare, Inc. (Name of Issuer) Common Stock, par value $0.00001 (Title of Class of Securities) 75988J106 (CUSIP Number) December 30, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant t |
|
| November 13, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Ex |
|
| August 13, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Exact n |
|
| July 9, 2015 |
S-8 1 rcars8.htm FORM S-8 As filed with the U.S. Securities and Exchange Commission on July 8, 2015 Registration No. 333- [·] UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 RenovaCare, Inc. (Exact name of registrant as specified in its charter) NEVADA 98-0170247 (State or other jurisdiction of incorporation or |
|
| July 9, 2015 |
EX-24.1 4 rcarex241.htm POWER OF ATTORNEY EXHIBIT 24.1 KNOW ALL MEN BY THESE PRESENTS, that we, the undersigned officers and directors of RenovaCare, Inc., a Nevada corporation, do hereby constitute and appoint Thomas Bold, as his true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for him and in his name, place, and stead, in any and all capacities, to |
|
| June 10, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 5, 2015 Date of Report (Date of earliest event reported) RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-30156 (Commission File Number) 98-0384030 |
|
| June 10, 2015 |
EXHIBIT 10.1 Subscription Agreement This Subscription Agreement (this ?Agreement?) is entered into by and between RenovaCare, Inc., a corporation organized under the laws of the State of Nevada (the ?Company?) and the subscriber whose name is set forth on the signature pages affixed hereto (the ?Subscriber?). R E C I T A L S WHEREAS, the Company is offering (the ?Offering?) for sale up to a maximu |
|
| June 10, 2015 |
EXHIBIT 4.1 NEITHER THIS SECURITY NOR ANY SECURITIES WHICH MAY BE ISSUED UPON EXERCISE OF THIS SECURITY HAVE BEEN REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY U.S. STATE OR OTHER JURISDICTION OR ANY EXCHANGE OR SELF-REGULATORY ORGANIZATION, IN RELIANCE UPON EXEMPTIONS FROM REGISTRATION UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AM |
|
| May 20, 2015 |
As filed with the U.S. Securities and Exchange Commission on May 20, 2015 As filed with the U.S. Securities and Exchange Commission on May 20, 2015 Registration No. 333-198600 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST EFFECTIVE AMENDMENT NO. 1 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 7389 98-0384030 (State or other jurisdiction of (Primary Sta |
|
| May 12, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Exact |
|
| May 5, 2015 |
EXHIBIT 10.1 OPTION AGREEMENT THIS OPTION AGREEMENT (this ?Agreement?) by and among RenovaCare, Inc., a Nevada corporation (the ?Optionee?) and J?rg Gerlach, MD, PhD, an individual having a place of residence at [ADDRESS] (the ?Optionor?), is entered into as of the first day of May, 2015. Optionee and the Optionor together may be referred to herein as the ?Parties? and each of them may be referred |
|
| May 5, 2015 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 1, 2015 Date of Report (Date of earliest event reported) RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-30156 (Commission File Number) 98-0384030 |
|
| March 20, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Exact name |
|
| December 8, 2014 |
RCAR / RenovaCare, Inc. CORRESP - - CORRESP 1 filename1.htm RenovaCare, Inc. 430 Park Avenue New York, NY 10022 Via EDGAR United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, DC 20549 December 8, 2014 Re: RenovaCare, Inc. Registration Statement On Form S-1 File No. 333-198600 To whom it may concern, On behalf of RenovaCare, Inc. (the “Registrant”) and in accordance with Rule 461 |
|
| November 20, 2014 |
EX-99.1 4 rcarex991.htm INCENTIVE STOCK OPTION PLAN EXHIBIT 99.1 May 15, 2014 BY EMAIL RenovaCare, Inc. 430 Park Avenue Suite 702 New York, NY 10022 Attention: Thomas Bold, President & CEO RE: Registration Rights Agreement with Kalen Capital Corporation Dear Mr. Bold, Reference is hereby made to the Registration Rights Agreement entered into between Kalen Capital Corporation and RenovaCare, Inc. ( |
|
| November 20, 2014 |
RCAR / RenovaCare, Inc. S-1/A - - FORM S-1/A AS FILED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION ON NOVEMBER 20 , 2014 Registration No. 333-198600 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A Pre-Effective Amendment No. 2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 7389 98-0384030 (State or other jurisdiction of (Prim |
|
| November 13, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Ex |
|
| October 20, 2014 |
RCAR / RenovaCare, Inc. S-1/A - - FORM S-1/A As filed with the U.S. Securities and Exchange Commission on October 20, 2014 Registration No. 333-198600 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A Pre-Effective Amendment No. 1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 7389 98-0384030 (State or other jurisdiction of (Primar |
|
| October 20, 2014 |
RCAR / RenovaCare, Inc. CORRESP - - October 20, 2014 Via EDGAR United States Securities and Exchange Commission Division of Corporation Finance Washington, D. |
|
| September 15, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 9, 2014 Date of Report (Date of earliest event reported) RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-30156 (Commission File Number) 98-03 |
|
| September 15, 2014 |
EX-10.1 2 rcarex101.htm POST-CLOSING AMENDMENT EXHIBIT 10.1 This Post-Closing Amendment to the Asset Purchase Agreement (the “Agreement”) is entered into as of September 9, 2014, and by and among RenovaCare, Inc., a Nevada corporation (the “Parent”), RenovaCare Sciences Corp., a Nevada corporation and wholly owned subsidiary of the Parent (the “Buyer”) and Jörg Gerlach, MD, PhD, an individual havi |
|
| September 5, 2014 |
EX-24.1 4 rcarex241.htm POWER OF ATTORNEY EXHIBIT 24.1 KNOW ALL MEN BY THESE PRESENTS, that we, the undersigned officers and directors of RenovaCare, Inc., a Nevada corporation, do hereby constitute and appoint Thomas Bold, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for him or and in his or her name, place, and stead, in any and a |
|
| September 5, 2014 |
S-1 1 rcars1.htm FORM S-1 As filed with the U.S. Securities and Exchange Commission on September 5, 2014 Registration No. 333- U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada 7389 98-0384030 (State or other jurisdiction of (Primary Standard |
|
| August 20, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 14, 2014 Date of Report (Date of earliest event reported) RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-30156 (Commission File Number) 98-0384 |
|
| August 14, 2014 | ||
| August 14, 2014 | ||
| August 14, 2014 |
0001016708 2014-01-01 2014-06-30 0001016708 2014-08-14 0001016708 2013-12-31 0001016708 us-gaap:OfficerMember rcar:FeeMember 2014-04-01 2014-06-30 0001016708 us-gaap:OfficerMember rcar:FeeMember 2013-04-01 2013-06-30 0001016708 us-gaap:DirectorMember rcar:LegalFeeMember 2013-04-01 2013-06-30 0001016708 2014-06-30 0001016708 2013-01-01 2013-06-30 0001016708 us-gaap:CommonStockMember 2013-01-01 2013 |
|
| August 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Exact n |
|
| August 14, 2014 |
XBRL TAXONOMY EXTENSION LABEL LINKBASE Officer and directors [Member] Related Party [Axis] Management Fee [Member] Title of Individual [Axis] Directors [Member] Legal Fee [Member] Advisory Fees Common Stock Equity Components [Axis] Additional Paid-In Capital Accumulated deficit Accumulated other comprehensive (loss) Oil And Gas Properties, Net [Member] Property, Plant and Equipment, Type [Axis] Total Liabilities [Member] Liability Clas |
|
| August 14, 2014 | ||
| August 14, 2014 |
00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONS |
|
| May 13, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Exact |
|
| April 7, 2014 |
EX-10.1 2 rcarex101.htm AT-WILL CONSULTING AGREEMENT EXHIBIT 10.1 430 Park Avenue Suite 702 New York, NY 10022 March 30, 2014 Ms. Patsy Trisler [ADDRESS] Re: At-Will Consulting Agreement with RenovaCare, Inc. Dear Patsy: This At-Will Consulting Agreement (the “Agreement”) sets forth the terms and conditions of your engagement as an independent consultant to and by RenovaCare, Inc. (the “Company”). |
|
| April 7, 2014 |
EXHIBIT 10.2 THIS NONSTATUTORY STOCK OPTION AGREEMENT (“Agreement”) is made and entered into as of April 1, 2014, by and between RenovaCare, Inc. a Nevada corporation (the “Company”), and Patsy Trisler (“Recipient”): This Agreement has been executed and delivered pursuant to the At-Will Consulting Agreement dated April 1, 2014 (between the Recipient and the Company (the “Consulting Agreement”). In |
|
| April 7, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 1, 2014 Date of Report (Date of earliest event reported) RenovaCare, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-30156 (Commission File Number) 98-017025 |
|
| March 28, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-30156 RENOVACARE, INC. (Exact name |
|
| January 10, 2014 |
8-K 1 rcar8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 7, 2014 Date of Report (Date of earliest event reported) RenovaCare, Inc. (Exact name of registrant as specified in its charter) Janus Resources, Inc. (Former name if changed since last report) Nevad |
|
| January 10, 2014 |
EXHIBIT 3.1 |
|
| January 10, 2014 |
EXHIBIT 3.2 |
|
| January 7, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 31, 2013 Date of Report (Date of earliest event reported) Janus Resources, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-30156 (Commission File Number) |
|
| January 7, 2014 |
EXHIBIT 2.1 STOCK PURCHASE AGREEMENT THE SECURITIES TO WHICH THIS AGREEMENT RELATES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”) AND THE RULES AND REGULATIONS PROMULGATED THEREUNDER AND MAY NOT BE OFFERED OR SOLD DIRECTLY OR INDIRECTLY WITHIN THE UNITED STATES OR TO OR FOR THE ACCOUNT OR BENEFIT OF U.S. PERSONS (AS DEFINED IN REGULATION S) EX |
|
| December 27, 2013 |
JANUS RESOURCES, INC. SERIES A COMMON STOCK PURCHASE WARRANT EXHIBIT 4.1 Portions of this exhibit marked [****] have been omitted pursuant to a request for confidential treatment under Rule 24b-2 under the Securities Exchange Act of 1934. The omitted materials have been filed separately with the Securities and Exchange Commission. NEITHER THIS SECURITY NOR ANY SECURITIES WHICH MAY BE ISSUED UPON EXERCISE OF THIS SECURITY HAVE BEEN REGISTERED WITH THE UNITED |
|
| December 27, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 12, 2013 Date of Report (Date of earliest event reported) Janus Resources, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-30156 (Commission File Number) 98 |
|
| December 27, 2013 |
EXHIBIT 10.1 Portions of this exhibit marked [****] have been omitted pursuant to a request for confidential treatment under Rule 24b-2 under the Securities Exchange Act of 1934. The omitted materials have been filed separately with the Securities and Exchange Commission. ASSET PURCHASE AGREEMENT THIS ASSET PURCHASE AGREEMENT (the “Agreement”) by and among Janus Resources, Inc., a Nevada corporati |
|
| December 17, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(C) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) x Definitive |
|
| December 5, 2013 |
EXHIBIT 4.2 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of November 29, 2013, between Janus Resources, Inc., a corporation organized under the laws of the State of Nevada (the “Company”), and Kalen Capital Corporation, a corporation organized under the laws of the Province of Alberta, Canada (“Investor”). Company and Investor may |
|
| December 5, 2013 |
EXHIBIT 4.1 NEITHER THIS SECURITY NOR ANY SECURITIES WHICH MAY BE ISSUED UPON EXERCISE OF THIS SECURITY HAVE BEEN REGISTERED WITH THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY U.S. STATE OR OTHER JURISDICTION OR ANY EXCHANGE OR SELF-REGULATORY ORGANIZATION, IN RELIANCE UPON EXEMPTIONS FROM REGISTRATION UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AM |
|
| December 5, 2013 |
EXHIBIT 10.3 Janus Resources, Inc. 430 Park Avenue Suite 702 New York, NY 10022 November 28, 2013 Mr. Thomas Bold [ADDRESS] Re: Your At-Will Consulting Agreement with Janus Resources, Inc. Dear Mr. Bold: This letter (the “Agreement”) sets forth the terms and conditions of your engagement as an independent consultant to and by Janus Resources, Inc. (the “Company”). For the purposes of this Agreemen |
|
| December 5, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 29, 2013 Date of Report (Date of earliest event reported) Janus Resources, Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-30156 (Commission File Number) |
|
| December 5, 2013 |
EXHIBIT 10.2 LOCK-UP AGREEMENT THIS LOCK-UP AGREEMENT (this “Agreement”) is made and entered into as of November 29, 2013 (the “Effective Date”) by and among Janus Resources, Inc. a corporation organized under the laws of the State of Nevada (the “Company”) and Kalen Capital Corporation, a corporation organized under the laws of the Province of Alberta, Canada (“Shareholder”). The Company and Shar |
